Your browser doesn't support javascript.
loading
Situación actual de la hepatitis B en Chile / Present situation of hepatitis B in Chile
Pereira S., Ana; Valenzuela B., María Teresa; Mora, Judith; Vera, Lilian.
Afiliação
  • Pereira S., Ana; Universidad de Chile. Facultad de Medicina. Escuela de Salud Pública. División de Epidemiología. CL
  • Valenzuela B., María Teresa; Universidad de los Andes. Facultad de Medicina. Departamento Salud Pública y Epidemiología. CL
  • Mora, Judith; Instituto de Salud Pública de Chile. Subdepartamento de Virología. CL
  • Vera, Lilian; Instituto de Salud Pública de Chile. Subdepartamento de Virología. CL
Rev. méd. Chile ; 136(6): 725-732, jun. 2008. tab
Article em Es | LILACS | ID: lil-490757
Biblioteca responsável: BR1.1
ABSTRACT

Background:

Hepatitis B virus infection generates carriers and 8 percent will evolve to a chronic phase.

Aim:

To perform a compilation of studies on hepatitis B in Chile and other sources of information to estímate the impact of this disease in our country. Material and

methods:

Published and unpublished evidence about the infection, in the general population and risk groups in our country, was compiled and reviewed critically. Informal interviews to experts, revisión of the mandatory notification book of the Ministry of Health and collection of data from laboratories that study hepatitis B virus, were also carried out.

Results:

The seroprevalence of chronic carriers in blood donors is nearly O.3 percent. Among risk groups such as health care personnel, the figure is O.7 percent, among homosexuals 29 percent, among HIV positive patients 30 percent, among sexual workers 2 percent and among children with chronic hemodialysis, 9 percent. Prevalence rate according to notified cases in 2004 was 1.8 x 100,000 habitants. Detection of viral hepatitis B surface antigen in ¡aboratories occurs in 0.2 percent of donors and 1.396 of non donors.

Conclusions:

The seroprevalence of hepatitis B virus, the lack of notification, and the introduction of hepatitis B vaccine to our Regular Program of Immunizations, are arguments to develop in Chile a hepatitis B and C surveillance system.
Assuntos
Palavras-chave
Texto completo: 1 Temas: ECOS / Estado_mercado_regulacao Bases de dados: LILACS Assunto principal: Hepatite B Tipo de estudo: Incidence_studies / Prevalence_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Adolescent / Adult / Child / Female / Humans / Male / Pregnancy País/Região como assunto: America do sul / Chile Idioma: Es Revista: Rev. méd. Chile Assunto da revista: MEDICINA Ano de publicação: 2008 Tipo de documento: Article País de afiliação: Chile
Texto completo: 1 Temas: ECOS / Estado_mercado_regulacao Bases de dados: LILACS Assunto principal: Hepatite B Tipo de estudo: Incidence_studies / Prevalence_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Adolescent / Adult / Child / Female / Humans / Male / Pregnancy País/Região como assunto: America do sul / Chile Idioma: Es Revista: Rev. méd. Chile Assunto da revista: MEDICINA Ano de publicação: 2008 Tipo de documento: Article País de afiliação: Chile